A swiss pharmaceutical company announced the development of a vaccine that makes cats less able to produce allergens thereby lessening the likelihood of an owner developing an allergy.
Cat allergy vaccine for humans.
These antibodies bind to fel d 1 and thus have the ability to lower or neutralize its.
Cats treated with the vaccine were found to be less likely to trigger allergic reactions in humans exposed to them.
Earlier this year hypopet ag announced in a press release that it was developing a vaccine that targets fel d 1 a.
During lab experiments the company gathered more than 50 young cats and provided three doses of the vaccine for nine weeks.
A study provides evidence that cat vaccination against the major cat allergen fe1 d 1 can reduce fel d 1 level in cat secretions and potentially minimize its.
Rather it attempts to train the immune system of cats.
A new cat allergy vaccine that s administered to pets themselves not people.
The cat allergy vaccine may help prevent rashes nasal congestion and irritated eyes and may reduce the risk of asthma or developing chronic respiratory issues new york post reported wednesday.
The vaccine for felines that hypopet has been working on induces anti fel d 1 antibodies in the cat.
Finally when samples from your catrades who got the vaccine were mixed with blood from.
A team of scientists from the swiss firm hypopet ag has developed a vaccine to combat the feline produced protein fel d 1 to which 10 of humans are allergic according to their press release.
News for patients with cat allergy.
Moreover your catrades who got the vaccine tended to have lower levels of fel d 1 in their saliva and tears.